Literature DB >> 23347508

Hydrogels for lentiviral gene delivery.

Stephanie K Seidlits1, Robert Michael Gower, Jaclyn A Shepard, Lonnie D Shea.   

Abstract

INTRODUCTION: Gene delivery from hydrogel biomaterials provides a fundamental tool for a variety of clinical applications including regenerative medicine, gene therapy for inherited disorders and drug delivery. The high water content and mild gelation conditions of hydrogels support their use for gene delivery by preserving activity of lentiviral vectors and acting to shield vectors from any host immune response. AREAS COVERED: Strategies to control lentiviral entrapment within and retention/release from hydrogels are reviewed. The authors discuss the ability of hydrogel design parameters to control the transgene expression profile and the capacity of hydrogels to protect vectors from (and even modulate) the host immune response. EXPERT OPINION: Delivery of genetic vectors from scaffolds provides a unique opportunity to capitalize on the potential synergy between the biomaterial design for cell processes and gene delivery. Hydrogel properties can be tuned to directly control the events that determine the tissue response to controlled gene delivery, which include the extent of cell infiltration, preservation of vector activity and vector retention. While some design parameters have been identified, numerous opportunities for investigation are available in order to develop a complete model relating the biomaterial properties and host response to gene delivery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23347508      PMCID: PMC3648640          DOI: 10.1517/17425247.2013.764864

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  69 in total

Review 1.  Gelatin as a delivery vehicle for the controlled release of bioactive molecules.

Authors:  Simon Young; Mark Wong; Yasuhiko Tabata; Antonios G Mikos
Journal:  J Control Release       Date:  2005-11-02       Impact factor: 9.776

2.  Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy.

Authors:  T Vandendriessche; L Thorrez; A Acosta-Sanchez; I Petrus; L Wang; L Ma; L DE Waele; Y Iwasaki; V Gillijns; J M Wilson; D Collen; M K L Chuah
Journal:  J Thromb Haemost       Date:  2006-09-26       Impact factor: 5.824

Review 3.  Bone tissue engineering by gene delivery.

Authors:  Michelle D Kofron; Cato T Laurencin
Journal:  Adv Drug Deliv Rev       Date:  2006-06-21       Impact factor: 15.470

4.  A macroporous hydrogel for the coculture of neural progenitor and endothelial cells to form functional vascular networks in vivo.

Authors:  Millicent C Ford; James P Bertram; Sara Royce Hynes; Michael Michaud; Qi Li; Michael Young; Steven S Segal; Joseph A Madri; Erin B Lavik
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-10       Impact factor: 11.205

5.  In vitro evaluation of macroporous hydrogels to facilitate stem cell infiltration, growth, and mineralization.

Authors:  Vandana Keskar; Nicholas W Marion; Jeremy J Mao; Richard A Gemeinhart
Journal:  Tissue Eng Part A       Date:  2009-07       Impact factor: 3.845

6.  Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo.

Authors:  Martha E Kidd; Seungjin Shin; Lonnie D Shea
Journal:  J Control Release       Date:  2011-09-01       Impact factor: 9.776

Review 7.  Advances in the development of non-human viral DNA-vectors for gene delivery.

Authors:  Peter Löser; Andreas Hüser; Moritz Hillgenberg; Daniel Kümin; Gerald W Both; Christian Hofmann
Journal:  Curr Gene Ther       Date:  2002-05       Impact factor: 4.391

Review 8.  Controlled release systems for DNA delivery.

Authors:  Angela K Pannier; Lonnie D Shea
Journal:  Mol Ther       Date:  2004-07       Impact factor: 11.454

9.  Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease.

Authors:  Mario A Cabrera-Salazar; Eric M Roskelley; Jie Bu; Bradley L Hodges; Nelson Yew; James C Dodge; Lamya S Shihabuddin; Istvan Sohar; David E Sleat; Ronald K Scheule; Beverly L Davidson; Seng H Cheng; Peter Lobel; Marco A Passini
Journal:  Mol Ther       Date:  2007-07-17       Impact factor: 11.454

10.  In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance.

Authors:  Brian D Brown; Giovanni Sitia; Andrea Annoni; Ehud Hauben; Lucia Sergi Sergi; Anna Zingale; Maria Grazia Roncarolo; Luca G Guidotti; Luigi Naldini
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

View more
  14 in total

Review 1.  Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.

Authors:  Dayananda Kasala; A-Rum Yoon; Jinwoo Hong; Sung Wan Kim; Chae-Ok Yun
Journal:  Nanomedicine (Lond)       Date:  2016-06-27       Impact factor: 5.307

2.  Adhesive thermosensitive gels for local delivery of viral vectors.

Authors:  Jeanette M Caronia; Daniel W Sorensen; Hope M Leslie; Jop H van Berlo; Samira M Azarin
Journal:  Biotechnol Bioeng       Date:  2019-05-20       Impact factor: 4.530

Review 3.  MicroRNA delivery for regenerative medicine.

Authors:  Bo Peng; Yongming Chen; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2015-05-27       Impact factor: 15.470

Review 4.  Nanoparticulate drug delivery platforms for advancing bone infection therapies.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  Expert Opin Drug Deliv       Date:  2014-08-11       Impact factor: 6.648

5.  Aligned Nanofibrillar Scaffolds for Controlled Delivery of Modified mRNA.

Authors:  Tatiana S Zaitseva; Cynthia Alcazar; Maedeh Zamani; Luqia Hou; Steve Sawamura; Eduard Yakubov; Michael Hopkins; Y Joseph Woo; Michael V Paukshto; Ngan F Huang
Journal:  Tissue Eng Part A       Date:  2018-06-20       Impact factor: 3.845

Review 6.  Gene delivery strategies to promote spinal cord repair.

Authors:  Christopher M Walthers; Stephanie K Seidlits
Journal:  Biomark Insights       Date:  2015-04-09

7.  Preparation and characterization of gelatin-based mucoadhesive nanocomposites as intravesical gene delivery scaffolds.

Authors:  Ching-Wen Liu; Li-Ching Chang; Kai-Jen Lin; Tsan-Jung Yu; Ching-Chung Tsai; Hao-Kuang Wang; Tong-Rong Tsai
Journal:  Biomed Res Int       Date:  2014-12-15       Impact factor: 3.411

Review 8.  Innovations in gene and growth factor delivery systems for diabetic wound healing.

Authors:  Ashang Luwang Laiva; Fergal J O'Brien; Michael B Keogh
Journal:  J Tissue Eng Regen Med       Date:  2017-09-21       Impact factor: 3.963

9.  Hydrogel-Based Controlled Delivery Systems for Articular Cartilage Repair.

Authors:  Ana Rey-Rico; Henning Madry; Magali Cucchiarini
Journal:  Biomed Res Int       Date:  2016-08-23       Impact factor: 3.411

10.  Projection Stereolithographic Fabrication of BMP-2 Gene-activated Matrix for Bone Tissue Engineering.

Authors:  Hang Lin; Ying Tang; Thomas P Lozito; Nicholas Oyster; Robert B Kang; Madalyn R Fritch; Bing Wang; Rocky S Tuan
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.